ArticleAntibodies (Basel, Switzerland)2024

Generation, Characterization, and Preclinical Studies of a Novel NKG2A-Targeted Antibody BRY805 for Cancer Immunotherapy.

Yaqiong Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.